Acino Acquires M8 Pharmaceuticals

Acino Acquires Select IlmixGroup Pharmaceutical Portfolio in Russia

April 1, 2021

Pharmaceuticals

Acino has completed the acquisition of a select portfolio of prescription pharmaceutical products and food supplements from the IlmixGroup group of companies in Russia. The deal (asset purchase) includes multiple brands used in gynaecology, oncology, urology and dermatology and is accompanied by manufacturing and supply agreements with MiraxBioPharma to ensure continued local production.

ADQ Acquires Acino from Avista Capital and Nordic Capital

September 16, 2021

Pharmaceuticals

Abu Dhabi holding company ADQ has agreed to acquire Acino, a Swiss pharmaceutical company headquartered in Zurich, from private equity owners Avista Capital Partners and Nordic Capital. The transaction supports ADQ's strategy to build a regional pharmaceuticals and healthcare platform, expanding capabilities in manufacturing, commercialization and distribution across emerging markets.

New Mountain Capital Acquires Aceto Chemicals Business

April 16, 2019

Manufacturing

New Mountain Capital, through an affiliate, agreed to acquire the chemicals business of ACETO Corporation (Aceto), a Port Washington, New York-based supplier and distributor of pharmaceutical ingredients and specialty chemicals. The acquisition is intended to provide Aceto with financial and strategic resources to scale capabilities, pursue organic and inorganic growth, and strengthen its position in life sciences and specialty materials markets.

Sanofi Acquires Amunix Pharmaceuticals

December 21, 2021

Biotechnology

Sanofi has entered into an agreement to acquire Amunix Pharmaceuticals for an upfront payment of approximately $1.0 billion plus up to $225 million in potential development milestones. The acquisition gives Sanofi Amunix’s Pro‑XTEN/XPAT/XPAC masking technology and a pipeline of conditionally activated T‑cell engagers and cytokine therapies (including lead candidate AMX‑818), expanding Sanofi’s immuno‑oncology capabilities.

Adragos Pharma Acquires Baccinex

February 6, 2025

Pharmaceuticals

Adragos Pharma, a Munich-headquartered CDMO, has acquired Baccinex, a Swiss sterile fill-finish specialist based in Courroux, Jura. The acquisition adds a US FDA- and EU-GMP-certified 6,200 m² facility and over 110 sterile fill-finish experts to Adragos' global manufacturing network, enhancing its clinical and commercial sterile manufacturing capabilities.

Aceto Acquires A&C (A&C Bio-Buffer)

April 15, 2021

Pharmaceuticals

Aceto has acquired A&C, a global GMP manufacturer of specialty excipients, buffers and process solutions, expanding Aceto's self-manufacturing and custom product capabilities for the vaccine, cell culture and biopharmaceutical markets. The deal adds GMP manufacturing, packaging and ingredient offerings and expands Aceto's North American and European footprint; financial terms were not disclosed.